Biotechnology in France industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of the industry’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by value and/or volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2007 annual average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe. 

EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Five Forces Analysis 12
5.1 Summary 12
5.2 Buyer Power 13
5.3 Supplier Power 14
5.4 New Entrants 15
5.5 Substitutes 16
5.6 Rivalry 17
CHAPTER 6 Leading Companies 18
6.1 Transgene 18
6.2 BioAlliance Pharma SA 21
6.3 BioMerieux 22
6.4 Merck KGaA 24
CHAPTER 7 Market Forecasts 26
7.1 Market Value Forecast 26
CHAPTER 8 Demographics 27
CHAPTER 9 Appendix 29
9.1 Methodology 29
9.2 Related Datamonitor Research 30

LIST OF TABLES
Table 1: France Biotechnology Market Value: $ million, 2003-2007 9
Table 2: France Biotechnology Market Segmentation I: % Share, by Value, 2007 10
Table 3: France Biotechnology Market Segmentation II: % Share, by Value, 2007 11
Table 1: Key Facts: Transgene 18
Table 2: Key Financials: Transgene 20
Table 3: Key Facts: BioAlliance Pharma SA 21
Table 4: Key Facts: BioMerieux 22
Table 5: Key Financials: BioMerieux 23
Table 6: Key Facts: Merck KGaA 24
Table 7: Key Financials: Merck KGaA 25
Table 8: France Biotechnology Market Value Forecast: $ million, 2007-2012 26
Table 9: France Size of Population (million) , 2003-2007 27
Table 10: France GDP (Constant 2000 Prices, $ billion), 2003-2007 27
Table 11: France Inflation, 2003-2007 27
Table 12: France Exchange Rate, 2003 28